287410 — Jeisys Medical Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- KR₩961bn
- KR₩952bn
- KR₩143bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.71 | ||
| PEG Ratio (f) | 0.76 | ||
| EPS Growth (f) | 32.91% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.62 | ||
| Price to Tang. Book | 8.76 | ||
| Price to Free Cashflow | 98.03 | ||
| Price to Sales | 5.73 | ||
| EV to EBITDA | 22.3 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 27.16% | ||
| Return on Equity | 27.1% | ||
| Operating Margin | 22.74% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | n/a | n/a | 81,296 | 116,549.56 | 143,029.55 | 191,253 | 223,680 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +105.91 | -13.06 | +71.62 | +28.9 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Jeisys Medical Inc is a Korea-based company principally engaged in the manufacturing and distribution of medical devices. The Company manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and LinearZ. In addition, the Company also provides consumables such as cartridges and tips.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- December 1st, 2017
- Public Since
- May 8th, 2018
- No. of Shareholders
- 24,156
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 74,485,307
- Address
- 76, Eulji-ro, Jung-gu, SEOUL, 08501
- Web
- https://www.jeisys.com/
- Phone
- +82 226036417
- Auditors
- Echon Accounting Corp.
Upcoming Events for 287410
Similar to 287410
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
What is the Jeisys Medical share price?
As of Today at 20:28 UTC, shares in Jeisys Medical are trading at KR₩12,900. This share price information is delayed by 15 minutes.
How has the Jeisys Medical share price performed this year?
Shares in Jeisys Medical last closed at KR₩12,900 and the price had moved by +24.76% over the past 365 days. In terms of relative price strength the Jeisys Medical share price has outperformed the FTSE Developed Asia Pacific Index by +16.97% over the past year.
What are the analyst and broker recommendations for Jeisys Medical?
The overall consensus recommendation for Jeisys Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Jeisys Medical dividend yield?
Jeisys Medical does not currently pay a dividend.
Does Jeisys Medical pay a dividend?
Jeisys Medical does not currently pay a dividend.
When does Jeisys Medical next pay dividends?
Jeisys Medical does not currently pay a dividend.
How do I buy Jeisys Medical shares?
To buy shares in Jeisys Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Jeisys Medical?
As of the previous close price of KR₩12,900, shares in Jeisys Medical had a market capitalisation of KR₩961bn.
Where are Jeisys Medical shares listed?
Here are the trading details for Jeisys Medical:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 287410
What kind of share is Jeisys Medical?
Based on an overall assessment of its quality, value and momentum Jeisys Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Jeisys Medical share price forecast for 2024?
The analyst consensus target price for shares in Jeisys Medical is KR₩13,925. That is 7.95% above the last closing price of KR₩12,900.
Analysts covering Jeisys Medical currently have a consensus Earnings Per Share (EPS) forecast of KR₩553 for the next financial year.
Find out moreWhat is the trend in the Jeisys Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jeisys Medical. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +8.04%.
As of the last closing price of KR₩12,900, shares in Jeisys Medical were trading +16.94% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Jeisys Medical PE Ratio?
The Jeisys Medical PE ratio based on its reported earnings over the past 12 months is 18.71. The shares last closed at KR₩12,900.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Jeisys Medical?
We do not have data on Jeisys Medical's directors